Article(id=1329367107445306181, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329367096166822579, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.01.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1734537600000, receivedDateStr=2024-12-19, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794875416860, onlineDateStr=2026-11-17, pubDate=1736438400000, pubDateStr=2025-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794875416860, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794875416860, creator=13701087609, updateTime=1794875416860, updator=13701087609, issue=Issue{id=1329367096166822579, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='1', pageStart='1', pageEnd='141', issueExtLink='null', onlineDate='null', pubDate='1736438400000', pubDateStr='2025-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794875414171, creator='13701087609', updateTime=1794887002143, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329415700000649272, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329367096166822579, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329415700000649273, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329367096166822579, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1, endPage=27, ext={EN=ArticleExt(id=1329367107655021382, articleId=1329367107445306181, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Overviews of the New Drugs in 2024 Approved by U.S. FDA, columnId=1327671169563603616, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives, runingTitle=null, highlight=null, articleAbstract=

In 2024, FDA approved 50 new drugs, including 31 chemical small molecules and 19 biological products. This review describes the descriptions, indications, mechanism of action, dosage forms and strengths, adverse reactions, and synthesis routes of all the small molecules, and the basic information about biological products.

, authors=Bo HAN1, 2, 3, Qingwei ZHANG1, 2, 3, *, authorsList=Bo HAN, Qingwei ZHANG, authorCompany=null, correspAuthors=Qingwei ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329367108321915721, articleId=1329367107445306181, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=2024年美国FDA批准上市新药简介, columnId=1327671169823650466, journalTitle=中国医药工业杂志, columnName=专论, runingTitle=null, highlight=null, articleAbstract=

2024年美国FDA批准上市新药50个,其中小分子药物31个,生物制品19个。根据FDA批准的新药说明书以及相关数据库和专利检索情况,文章简要介绍了2024年FDA批准的上市小分子药物的概况、适应证、作用机制、剂型规格、不良反应和合成路线等,以及生物制品的基本情况。

, authors=韩博1, 2, 3, 张庆伟1, 2, 3, *, authorsList=韩博, 张庆伟, authorCompany=null, correspAuthors=张庆伟, authorNote=

韩博(1999—),男,博士研究生,专业方向:药物化学。

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,上海交通大学、复旦大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,Pharmaceutical Fronts 编委,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科学技术奖评审专家。主要从事中枢神经系统、靶向肿瘤免疫等新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家十三五“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星、上海市东方英才计划拔尖项目等各类项目23项。主持发现 8 个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成10个医药品种的绿色工艺产业化开发。个人先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市“青年科技启明星”、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”等荣誉称号。作为第一作者或通信作者发表 JMC、EJMC、BMCL、CCL 等研究论文 60 余篇;进行国内外学术报告30 余次;合著英文专业书籍3 本;申请发明专利60 余项,专利许可转让20 余项。带教、指导博士、硕士研究生18 名,连续多年指导毕业生获“上海市优秀毕业生”。

, correspAuthorsNote=
张庆伟(1983—),男,研究员,博士生导师,从事原创性新药研究及医药品种产业化开发的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=Yiuz4gVxRBrkqzAHt5HN9w==, magXml=oApTTqE2HkR2+Pm4Kp57Nw==, pdfUrl=null, pdf=mWgcmwyk4e9ctbi5jp2Cjw==, pdfFileSize=2447779, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=WYPamU7N9sYdmOwQhOwDWg==, mapNumber=null, fund=null)}, authors=[Author(id=1329367108862980948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329367108997198680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367108862980948, language=EN, stringName=Bo HAN, firstName=Bo, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203
3.National Key Lab. of Lead Druggability Research, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329367109076890457, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367108862980948, language=CN, stringName=韩博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,上海 201203
3.先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

韩博(1999—),男,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

韩博(1999—),男,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329367108607128394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=1., ext=[AuthorCompanyExt(id=1329367108615517003, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329367108628099916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329367108691014477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=2., ext=[AuthorCompanyExt(id=1329367108695208782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203), AuthorCompanyExt(id=1329367108703597391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,上海 201203)]), AuthorCompany(id=1329367108774900560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=3., ext=[AuthorCompanyExt(id=1329367108779094865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.National Key Lab. of Lead Druggability Research, Shanghai 201203), AuthorCompanyExt(id=1329367108787483474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1329367109143999323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=sipiqingwei@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329367109211108191, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367109143999323, language=EN, stringName=Qingwei ZHANG, firstName=Qingwei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203
3.National Key Lab. of Lead Druggability Research, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329367109274022752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367109143999323, language=CN, stringName=张庆伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,上海 201203
3.先导物成药性研究全国重点实验室,上海 201203, bio={"img":"1ZM+9GQIR1+CtdVZmQPG0A==","content":"

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,上海交通大学、复旦大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,Pharmaceutical Fronts 编委,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科学技术奖评审专家。主要从事中枢神经系统、靶向肿瘤免疫等新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家十三五“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星、上海市东方英才计划拔尖项目等各类项目23项。主持发现 8 个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成10个医药品种的绿色工艺产业化开发。个人先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市“青年科技启明星”、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”等荣誉称号。作为第一作者或通信作者发表 JMC、EJMC、BMCL、CCL 等研究论文 60 余篇;进行国内外学术报告30 余次;合著英文专业书籍3 本;申请发明专利60 余项,专利许可转让20 余项。带教、指导博士、硕士研究生18 名,连续多年指导毕业生获“上海市优秀毕业生”。

"}, bioImg=1ZM+9GQIR1+CtdVZmQPG0A==, bioContent=

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,上海交通大学、复旦大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,Pharmaceutical Fronts 编委,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科学技术奖评审专家。主要从事中枢神经系统、靶向肿瘤免疫等新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家十三五“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星、上海市东方英才计划拔尖项目等各类项目23项。主持发现 8 个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成10个医药品种的绿色工艺产业化开发。个人先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市“青年科技启明星”、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”等荣誉称号。作为第一作者或通信作者发表 JMC、EJMC、BMCL、CCL 等研究论文 60 余篇;进行国内外学术报告30 余次;合著英文专业书籍3 本;申请发明专利60 余项,专利许可转让20 余项。带教、指导博士、硕士研究生18 名,连续多年指导毕业生获“上海市优秀毕业生”。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329367108607128394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=1., ext=[AuthorCompanyExt(id=1329367108615517003, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329367108628099916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329367108691014477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=2., ext=[AuthorCompanyExt(id=1329367108695208782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203), AuthorCompanyExt(id=1329367108703597391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,上海 201203)]), AuthorCompany(id=1329367108774900560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=3., ext=[AuthorCompanyExt(id=1329367108779094865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.National Key Lab. of Lead Druggability Research, Shanghai 201203), AuthorCompanyExt(id=1329367108787483474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.先导物成药性研究全国重点实验室,上海 201203)])])], keywords=[Keyword(id=1329367109374686049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=EN, orderNo=1, keyword=FDA), Keyword(id=1329367109450183522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=EN, orderNo=2, keyword=new drugs approval), Keyword(id=1329367109521486691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=EN, orderNo=3, keyword=indication), Keyword(id=1329367109588595556, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=EN, orderNo=4, keyword=mechanism of action), Keyword(id=1329367109655704421, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=EN, orderNo=5, keyword=synthetic route), Keyword(id=1329367109722813286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=CN, orderNo=1, keyword=FDA), Keyword(id=1329367109781533543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=CN, orderNo=2, keyword=新药上市), Keyword(id=1329367109844448104, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=CN, orderNo=3, keyword=适应证), Keyword(id=1329367109924139881, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=CN, orderNo=4, keyword=作用机制), Keyword(id=1329367109991248746, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, language=CN, orderNo=5, keyword=合成路线)], refs=[Reference(id=1329367110179992428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=周 薇, 林快乐, 周伟澄.2023年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2024, 55(1): 1-27., articleTitle=null, refAbstract=null), Reference(id=1329367110251295597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Novel drug approvals for 2024 [EB/OL].(2024-12-23)[2025-01-01].https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024., articleTitle=null, refAbstract=null), Reference(id=1329367110318404462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN W R, JENNIER C, LIOYD F, et al.Pyrimidine derivatives useful as raf kinase inhibitors: WO, 2009006389A2[P].2009-01-08., articleTitle=null, refAbstract=null), Reference(id=1329367110385513327, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ZENON D K, JANETA P M, JEREMY M T, et al.Therapeutically active compounds and their methods of use:WO, 2015003640A1 [P].2015-01-15., articleTitle=null, refAbstract=null), Reference(id=1329367110444233584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUL S B, DEVIDAS S G P, JAEKYOO L, et al.Compounds and compositions for modulating egfr mutant kinase activities: WO, 2016060443A2 [P].2016-04-21., articleTitle=null, refAbstract=null), Reference(id=1329367110511342449, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=GABRIELLE B M, RICHARD E, EMILY H, et al.Benzoxazepin oxazolidinone compounds and methods of use:WO, 2017001645A1 [P].2017-01-05., articleTitle=null, refAbstract=null), Reference(id=1329367110574257010, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SALVACION C, DAVID A C, WAYNE D L, et al.Inhibitors of the menin-mll interaction: WO, 2017214367A1 [P].2017-12-14., articleTitle=null, refAbstract=null), Reference(id=1329367110645560179, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG C. Substituted pyridazine carboxamide compounds:WO, 2012048259A2 [P].2014-04-12., articleTitle=null, refAbstract=null), Reference(id=1329367110708474740, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=UDAYAMPALAYAM P S, GNANAPRAKASAM A,GANAPATHY P, et al.Novel 2-substituted methyl penam derivatives: US, 20080015156A1 [P].2008-01-17., articleTitle=null, refAbstract=null), Reference(id=1329367110783972213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=PAUL H, HANS H, ROLAND H.New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives:WO, 2001090111A1 [P].2001-11-29., articleTitle=null, refAbstract=null), Reference(id=1329367110842692470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=SALVACION C, DAVID A C, WAYNE D L, et al.Inhibitors of the menin-mll interaction: WO, 2017214367A1 [P].2017-12-14., articleTitle=null, refAbstract=null), Reference(id=1329367110909801335, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LASZLO U, ZITA J C, LAJOS G, et al.A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds: WO, 2001079174A1[P].2001-10-25., articleTitle=null, refAbstract=null), Reference(id=1329367110976910200, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ROBERT S, LIU J F, ADAM J M, et al.Deuterated derivatives of ruxolitinib: WO, 2013188783A1 [P].2013-12-19., articleTitle=null, refAbstract=null), Reference(id=1329367111044019065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=KEITH H D, ROBERT J D, MARTHA K, et al.Method of synthesizing thyroid hormone analogs and polymorphs thereof: WO, 2014043706A1 [P].2014-03-20., articleTitle=null, refAbstract=null), Reference(id=1329367111119516538, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=BOLLI M H, BOSS C, BINKERT C, et al.The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide(Macitentan), an orally active, potent dual endothelin receptor antagonist [J].J Med Chem, 2012, 55(17): 7849-7861., articleTitle=null, refAbstract=null), Reference(id=1329367111182431099, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=GIORGIO B, MAURO B, SILVIO A, et al.Compounds with anti-inflammatory and immunosuppressive activities: US,6034096A [P].2000-03-07., articleTitle=null, refAbstract=null), Reference(id=1329367111241151356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LANTHIER C M, GORIN B, OUDENES J, et al.Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids,esters and amides: US, 20120309977A1 [P]. 2012-12-06., articleTitle=null, refAbstract=null), Reference(id=1329367111312454525, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ALLAN W J, AVINASH S P, MILIND D, et al.Aryl,heteroaryl, and heterocyclic compounds for treatment of medical disorders: WO, 2017035353A1 [P].2017-03-02., articleTitle=null, refAbstract=null), Reference(id=1329367111383757694, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=BRIDGER G J, PELUS L M.Chemokine combinations to mobilize progenitor/stem cells: US, 20060035829A1 [P].2006-02-16., articleTitle=null, refAbstract=null), Reference(id=1329367111455060863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=JAMILA N, KARINE C B.Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives: WO, 2004005243A2[P].2004-01-15., articleTitle=null, refAbstract=null), Reference(id=1329367111526364032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ADRIAN S A.Processes for making, and methods of using,glycopyrronium compounds: WO, 2018026869A1 [P].2018-02-08., articleTitle=null, refAbstract=null), Reference(id=1329367111580889985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLIAM O A, JACK D.Derivatives of pyrimido[6,1-a]-isoquinolin-4-one: WO, 2000058308A1 [P].2000-10-05., articleTitle=null, refAbstract=null), Reference(id=1329367111652193154, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=KUO G H, ZHANG R, WANG A H, et al.4-[(Phenoxyalkyl)-thio]-phenoxyacetic acids and analogs: WO, 2005042478A2[P].2005-05-12., articleTitle=null, refAbstract=null), Reference(id=1329367111778022275, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=刘 飞, 李先朝, 赵 欣, 等.占诺美林的帕莫酸盐、晶型及其制备方法和用途: 中国, 114853750A [P].2022-08-05., articleTitle=null, refAbstract=null), Reference(id=1329367111853519748, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAEF I, ALHAMADSHEH M.ALHAMADSHEH.Transthyretin stabilizers and their use for inhibiting transthyretin amyloidosis and protein-protein interactions:WO, 2014100227A1 [P].2014-06-26., articleTitle=null, refAbstract=null), Reference(id=1329367111912240005, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=IGUCHI S, IWAMURA H, NISHIZAKI M, et al.Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101 [J].Chem Pharm Bull(Tokyo),1992, 40(6): 1462-1469., articleTitle=null, refAbstract=null), Reference(id=1329367111987737478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ROBERT H F, RAPHAEL L G, Zhang X P, et al.Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia: WO, 2020115555A2 [P].2020-06-11., articleTitle=null, refAbstract=null), Reference(id=1329367112042263431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=CLEMENS J J, ABELA A R, ANDERSON C D, et al.Modulators of cystic fibrosis transmembrane conductance regulator,pharmaceutical compositions, methods of treatment, and process for making the modulators: US, 20190248809A1 [P].2019-08-15., articleTitle=null, refAbstract=null), Reference(id=1329367112117760904, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Morgan A J.Deuterated derivatives of ivacaftor: WO,2012158885A1 [P].2012-11-22., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329367110083523435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, awardId=22ZR1460300, language=CN, fundingSource=上海市“科技创新行动计划”自然科学基金面上项目(22ZR1460300), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329367108607128394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=1., ext=[AuthorCompanyExt(id=1329367108615517003, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329367108628099916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329367108691014477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=2., ext=[AuthorCompanyExt(id=1329367108695208782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203), AuthorCompanyExt(id=1329367108703597391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,上海 201203)]), AuthorCompany(id=1329367108774900560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=3., ext=[AuthorCompanyExt(id=1329367108779094865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.National Key Lab. of Lead Druggability Research, Shanghai 201203), AuthorCompanyExt(id=1329367108787483474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.先导物成药性研究全国重点实验室,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.01.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.01.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.01.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.01.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1736438400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
2024年美国FDA批准上市新药简介
韩博 1, 2, 3 , 张庆伟 1, 2, 3, *
中国医药工业杂志 | 专论 2025,56(1): 1-27
收起
收藏切换
中国医药工业杂志 |专论 2025 , 56 (1) : 1 -27
2024年美国FDA批准上市新药简介
全屏
[Author(id=1329367108862980948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329367108997198680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367108862980948, language=EN, stringName=Bo HAN, firstName=Bo, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203
3.National Key Lab. of Lead Druggability Research, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329367109076890457, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367108862980948, language=CN, stringName=韩博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,上海 201203
3.先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

韩博(1999—),男,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

韩博(1999—),男,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329367108607128394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=1., ext=[AuthorCompanyExt(id=1329367108615517003, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329367108628099916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329367108691014477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=2., ext=[AuthorCompanyExt(id=1329367108695208782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203), AuthorCompanyExt(id=1329367108703597391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,上海 201203)]), AuthorCompany(id=1329367108774900560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=3., ext=[AuthorCompanyExt(id=1329367108779094865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.National Key Lab. of Lead Druggability Research, Shanghai 201203), AuthorCompanyExt(id=1329367108787483474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1329367109143999323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=sipiqingwei@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329367109211108191, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367109143999323, language=EN, stringName=Qingwei ZHANG, firstName=Qingwei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203
3.National Key Lab. of Lead Druggability Research, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329367109274022752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, authorId=1329367109143999323, language=CN, stringName=张庆伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,上海 201203
3.先导物成药性研究全国重点实验室,上海 201203, bio={"img":"1ZM+9GQIR1+CtdVZmQPG0A==","content":"

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,上海交通大学、复旦大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,Pharmaceutical Fronts 编委,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科学技术奖评审专家。主要从事中枢神经系统、靶向肿瘤免疫等新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家十三五“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星、上海市东方英才计划拔尖项目等各类项目23项。主持发现 8 个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成10个医药品种的绿色工艺产业化开发。个人先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市“青年科技启明星”、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”等荣誉称号。作为第一作者或通信作者发表 JMC、EJMC、BMCL、CCL 等研究论文 60 余篇;进行国内外学术报告30 余次;合著英文专业书籍3 本;申请发明专利60 余项,专利许可转让20 余项。带教、指导博士、硕士研究生18 名,连续多年指导毕业生获“上海市优秀毕业生”。

"}, bioImg=1ZM+9GQIR1+CtdVZmQPG0A==, bioContent=

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,上海交通大学、复旦大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,Pharmaceutical Fronts 编委,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科学技术奖评审专家。主要从事中枢神经系统、靶向肿瘤免疫等新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家十三五“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星、上海市东方英才计划拔尖项目等各类项目23项。主持发现 8 个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成10个医药品种的绿色工艺产业化开发。个人先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市“青年科技启明星”、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”等荣誉称号。作为第一作者或通信作者发表 JMC、EJMC、BMCL、CCL 等研究论文 60 余篇;进行国内外学术报告30 余次;合著英文专业书籍3 本;申请发明专利60 余项,专利许可转让20 余项。带教、指导博士、硕士研究生18 名,连续多年指导毕业生获“上海市优秀毕业生”。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329367108607128394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=1., ext=[AuthorCompanyExt(id=1329367108615517003, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329367108628099916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108607128394, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329367108691014477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=2., ext=[AuthorCompanyExt(id=1329367108695208782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203), AuthorCompanyExt(id=1329367108703597391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108691014477, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,上海 201203)]), AuthorCompany(id=1329367108774900560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, xref=3., ext=[AuthorCompanyExt(id=1329367108779094865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.National Key Lab. of Lead Druggability Research, Shanghai 201203), AuthorCompanyExt(id=1329367108787483474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329367107445306181, companyId=1329367108774900560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.先导物成药性研究全国重点实验室,上海 201203)])])]
韩博1, 2, 3, 张庆伟1, 2, 3, *
作者信息
  • 1.中国医药工业研究总院,上海 201203
  • 2.上海医药工业研究院有限公司,上海 201203
  • 3.先导物成药性研究全国重点实验室,上海 201203
通讯作者:
张庆伟(1983—),男,研究员,博士生导师,从事原创性新药研究及医药品种产业化开发的研究。E-mail:
作者简介:

韩博(1999—),男,博士研究生,专业方向:药物化学。

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,上海交通大学、复旦大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,Pharmaceutical Fronts 编委,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科学技术奖评审专家。主要从事中枢神经系统、靶向肿瘤免疫等新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家十三五“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星、上海市东方英才计划拔尖项目等各类项目23项。主持发现 8 个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成10个医药品种的绿色工艺产业化开发。个人先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市“青年科技启明星”、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”等荣誉称号。作为第一作者或通信作者发表 JMC、EJMC、BMCL、CCL 等研究论文 60 余篇;进行国内外学术报告30 余次;合著英文专业书籍3 本;申请发明专利60 余项,专利许可转让20 余项。带教、指导博士、硕士研究生18 名,连续多年指导毕业生获“上海市优秀毕业生”。

Overviews of the New Drugs in 2024 Approved by U.S. FDA
Bo HAN1, 2, 3, Qingwei ZHANG1, 2, 3, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.Shanghai Institute of Pharmaceutical Industry Co., Ltd.,Shanghai 201203
  • 3.National Key Lab. of Lead Druggability Research, Shanghai 201203
出版时间: 2025-01-10 doi: 10.16522/j.cnki.cjph.2025.01.001
文章导航
收藏切换

2024年美国FDA批准上市新药50个,其中小分子药物31个,生物制品19个。根据FDA批准的新药说明书以及相关数据库和专利检索情况,文章简要介绍了2024年FDA批准的上市小分子药物的概况、适应证、作用机制、剂型规格、不良反应和合成路线等,以及生物制品的基本情况。

FDA  /  新药上市  /  适应证  /  作用机制  /  合成路线

In 2024, FDA approved 50 new drugs, including 31 chemical small molecules and 19 biological products. This review describes the descriptions, indications, mechanism of action, dosage forms and strengths, adverse reactions, and synthesis routes of all the small molecules, and the basic information about biological products.

FDA  /  new drugs approval  /  indication  /  mechanism of action  /  synthetic route
韩博, 张庆伟. 2024年美国FDA批准上市新药简介. 中国医药工业杂志, 2025 , 56 (1) : 1 -27 . DOI: 10.16522/j.cnki.cjph.2025.01.001
Bo HAN, Qingwei ZHANG. Overviews of the New Drugs in 2024 Approved by U.S. FDA[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (1) : 1 -27 . DOI: 10.16522/j.cnki.cjph.2025.01.001
  • 上海市“科技创新行动计划”自然科学基金面上项目(22ZR1460300)
参考文献 引证文献
排序方式:
[1]
周 薇, 林快乐, 周伟澄.2023年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2024, 55(1): 1-27.
[2]
FDA.Novel drug approvals for 2024 [EB/OL].(2024-12-23)[2025-01-01].https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024.
[3]
CHEN W R, JENNIER C, LIOYD F, et al.Pyrimidine derivatives useful as raf kinase inhibitors: WO, 2009006389A2[P].2009-01-08.
[4]
ZENON D K, JANETA P M, JEREMY M T, et al.Therapeutically active compounds and their methods of use:WO, 2015003640A1 [P].2015-01-15.
[5]
CHUL S B, DEVIDAS S G P, JAEKYOO L, et al.Compounds and compositions for modulating egfr mutant kinase activities: WO, 2016060443A2 [P].2016-04-21.
[6]
GABRIELLE B M, RICHARD E, EMILY H, et al.Benzoxazepin oxazolidinone compounds and methods of use:WO, 2017001645A1 [P].2017-01-05.
[7]
SALVACION C, DAVID A C, WAYNE D L, et al.Inhibitors of the menin-mll interaction: WO, 2017214367A1 [P].2017-12-14.
[8]
LIANG C. Substituted pyridazine carboxamide compounds:WO, 2012048259A2 [P].2014-04-12.
[9]
UDAYAMPALAYAM P S, GNANAPRAKASAM A,GANAPATHY P, et al.Novel 2-substituted methyl penam derivatives: US, 20080015156A1 [P].2008-01-17.
[10]
PAUL H, HANS H, ROLAND H.New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives:WO, 2001090111A1 [P].2001-11-29.
[11]
SALVACION C, DAVID A C, WAYNE D L, et al.Inhibitors of the menin-mll interaction: WO, 2017214367A1 [P].2017-12-14.
[12]
LASZLO U, ZITA J C, LAJOS G, et al.A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds: WO, 2001079174A1[P].2001-10-25.
[13]
ROBERT S, LIU J F, ADAM J M, et al.Deuterated derivatives of ruxolitinib: WO, 2013188783A1 [P].2013-12-19.
[14]
KEITH H D, ROBERT J D, MARTHA K, et al.Method of synthesizing thyroid hormone analogs and polymorphs thereof: WO, 2014043706A1 [P].2014-03-20.
[15]
BOLLI M H, BOSS C, BINKERT C, et al.The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide(Macitentan), an orally active, potent dual endothelin receptor antagonist [J].J Med Chem, 2012, 55(17): 7849-7861.
[16]
GIORGIO B, MAURO B, SILVIO A, et al.Compounds with anti-inflammatory and immunosuppressive activities: US,6034096A [P].2000-03-07.
[17]
LANTHIER C M, GORIN B, OUDENES J, et al.Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids,esters and amides: US, 20120309977A1 [P]. 2012-12-06.
[18]
ALLAN W J, AVINASH S P, MILIND D, et al.Aryl,heteroaryl, and heterocyclic compounds for treatment of medical disorders: WO, 2017035353A1 [P].2017-03-02.
[19]
BRIDGER G J, PELUS L M.Chemokine combinations to mobilize progenitor/stem cells: US, 20060035829A1 [P].2006-02-16.
[20]
JAMILA N, KARINE C B.Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives: WO, 2004005243A2[P].2004-01-15.
[21]
ADRIAN S A.Processes for making, and methods of using,glycopyrronium compounds: WO, 2018026869A1 [P].2018-02-08.
[22]
WILLIAM O A, JACK D.Derivatives of pyrimido[6,1-a]-isoquinolin-4-one: WO, 2000058308A1 [P].2000-10-05.
[23]
KUO G H, ZHANG R, WANG A H, et al.4-[(Phenoxyalkyl)-thio]-phenoxyacetic acids and analogs: WO, 2005042478A2[P].2005-05-12.
[24]
刘 飞, 李先朝, 赵 欣, 等.占诺美林的帕莫酸盐、晶型及其制备方法和用途: 中国, 114853750A [P].2022-08-05.
[25]
GRAEF I, ALHAMADSHEH M.ALHAMADSHEH.Transthyretin stabilizers and their use for inhibiting transthyretin amyloidosis and protein-protein interactions:WO, 2014100227A1 [P].2014-06-26.
[26]
IGUCHI S, IWAMURA H, NISHIZAKI M, et al.Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101 [J].Chem Pharm Bull(Tokyo),1992, 40(6): 1462-1469.
[27]
ROBERT H F, RAPHAEL L G, Zhang X P, et al.Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia: WO, 2020115555A2 [P].2020-06-11.
[28]
CLEMENS J J, ABELA A R, ANDERSON C D, et al.Modulators of cystic fibrosis transmembrane conductance regulator,pharmaceutical compositions, methods of treatment, and process for making the modulators: US, 20190248809A1 [P].2019-08-15.
[29]
Morgan A J.Deuterated derivatives of ivacaftor: WO,2012158885A1 [P].2012-11-22.
2025年第56卷第1期
55
18
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.01.001
  • 接收时间:2024-12-19
  • 首发时间:2026-11-17
  • 出版时间:2025-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-12-19
基金
上海市“科技创新行动计划”自然科学基金面上项目(22ZR1460300)
作者信息
    1.中国医药工业研究总院,上海 201203
    2.上海医药工业研究院有限公司,上海 201203
    3.先导物成药性研究全国重点实验室,上海 201203

通讯作者:

张庆伟(1983—),男,研究员,博士生导师,从事原创性新药研究及医药品种产业化开发的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.01.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏